Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2008 2
2010 2
2011 1
2012 5
2013 6
2014 2
2015 3
2016 5
2017 6
2018 3
2019 4
2020 3
2021 10
2022 7
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Review: Targeting EZH2 in neuroblastoma.
Gao J, Fosbrook C, Gibson J, Underwood TJ, Gray JC, Walters ZS. Gao J, et al. Among authors: underwood tj. Cancer Treat Rev. 2023 Sep;119:102600. doi: 10.1016/j.ctrv.2023.102600. Epub 2023 Jul 13. Cancer Treat Rev. 2023. PMID: 37467626 Free article. Review.
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
Moore JL, Green M, Santaolalla A, Deere H, Evans RPT, Elshafie M, Lavery A, McManus DT, McGuigan A, Douglas R, Horne J, Walker R, Mir H, Terlizzo M, Kamarajah SK, Van Hemelrijck M, Maisey N, Sita-Lumsden A, Ngan S, Kelly M, Baker CR, Kumar S, Lagergren J, Allum WH, Gossage JA, Griffiths EA, Grabsch HI, Turkington RC, Underwood TJ, Smyth EC, Fitzgerald RC, Cunningham D, Davies AR; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) study group, The Guy's and St Thomas' Oesophago-gastric Research Group, and The PROGRESS study group. Moore JL, et al. Among authors: underwood tj. J Clin Oncol. 2023 Oct 1;41(28):4522-4534. doi: 10.1200/JCO.23.00139. Epub 2023 Jul 27. J Clin Oncol. 2023. PMID: 37499209
Identification of neoantigens in oesophageal adenocarcinoma.
Nicholas B, Bailey A, McCann KJ, Wood O, Walker RC, Parker R, Ternette N, Elliott T, Underwood TJ, Johnson P, Skipp P. Nicholas B, et al. Among authors: underwood tj. Immunology. 2023 Mar;168(3):420-431. doi: 10.1111/imm.13578. Epub 2022 Oct 19. Immunology. 2023. PMID: 36111495 Free article.
A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium.
Peters CJ, Ang Y, Ciccarelli FD, Coles H, Coleman HG, Contino G, Crosby T, Devonshire G, Eldridge M, Freeman A, Grehan N, McCord M, Nutzinger B, Zamani S, Parsons SL, Petty R, Sharrocks AD, Skipworth RJE, Smyth EC, Soomro I, Underwood TJ; OCCAMS Consortium; Fitzgerald RC. Peters CJ, et al. Among authors: underwood tj. Nat Med. 2024 Jan;30(1):14-16. doi: 10.1038/s41591-023-02676-y. Nat Med. 2024. PMID: 38114667 No abstract available.
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.
O'Brien E, Tse C, Tracy I, Reddin I, Selfe J, Gibson J, Tapper W, Pengelly RJ, Gao J, Aladowicz E, Petts G, Thway K, Popov S, Kelsey A, Underwood TJ, Shipley J, Walters ZS. O'Brien E, et al. Among authors: underwood tj. Clin Epigenetics. 2023 Oct 19;15(1):167. doi: 10.1186/s13148-023-01583-w. Clin Epigenetics. 2023. PMID: 37858275 Free PMC article.
66 results